Literature DB >> 22806943

Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.

Simon P Fletcher1, Daniel J Chin, Donavan T Cheng, Palanikumar Ravindran, Hans Bitter, Lore Gruenbaum, Paul J Cote, Han Ma, Klaus Klumpp, Stephan Menne.   

Abstract

UNLABELLED: The woodchuck model of hepatitis B virus (HBV) infection displays many characteristics of human infection and has particular value for characterizing the host immune responses during the development of chronic infection. Using the newly developed custom woodchuck microarray platform, we compared the intrahepatic transcriptional profiles of neonatal woodchucks with self-limiting woodchuck hepatitis virus (WHV) infection to those woodchucks progressing to persistent WHV infection. This revealed that WHV does not induce significant intrahepatic gene expression changes during the early-acute stage of infection (8 weeks), suggesting it is a stealth virus. At the mid-acute phase of infection (14 weeks), resolution was associated with induction of a prominent cytotoxic T-cell signature. Strikingly, this was accompanied by high-level expression of PD-1 and various other inhibitory T-cell receptors, which likely act to minimize liver damage by cytotoxic T cells during viral clearance. In contrast to the expression of perforin and other cytotoxic effector genes, the interferon-γ (IFN-γ) signaling response in the mid-acute phase was comparable to that in chronically infected adult animals. The absence of a strong IFN-α/β transcriptional response indicated that type I IFN is not a critical mediator of self-limiting infection. Nevertheless, a number of antiviral genes, including viperin, were differentially expressed during resolving infection, suggesting that a subset of IFN-stimulated genes (ISG) may play a role in the control of WHV replication.
CONCLUSION: We identified new immune pathways associated with the clearance of hepadnavirus infection revealing novel molecular targets with potential for the therapeutic treatment of chronic hepatitis B.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22806943      PMCID: PMC3525799          DOI: 10.1002/hep.25954

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  43 in total

Review 1.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Authors:  Robert Thimme; Stefan Wieland; Carola Steiger; John Ghrayeb; Keith A Reimann; Robert H Purcell; Francis V Chisari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Role of type 1 versus type 2 immune responses in liver during the onset of chronic woodchuck hepatitis virus infection.

Authors:  Yun Wang; Stephan Menne; James R Jacob; Bud C Tennant; John L Gerin; Paul J Cote
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

4.  Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection.

Authors:  P J Cote; I Toshkov; C Bellezza; M Ascenzi; C Roneker; L Ann Graham; B H Baldwin; K Gaye; I Nakamura; B E Korba; B C Tennant; J L Gerin
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

5.  Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor-alpha messenger RNAs.

Authors:  I Nakamura; J T Nupp; M Cowlen; W C Hall; B C Tennant; J L Casey; J L Gerin; P J Cote
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  Genomic analysis of the host response to hepatitis B virus infection.

Authors:  Stefan Wieland; Robert Thimme; Robert H Purcell; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

7.  Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes.

Authors:  Y Wang; J R Jacob; S Menne; C A Bellezza; B C Tennant; J L Gerin; P J Cote
Journal:  J Viral Hepat       Date:  2004-09       Impact factor: 3.728

Review 8.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

Authors:  D Lavanchy
Journal:  J Viral Hepat       Date:  2004-03       Impact factor: 3.728

9.  Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes.

Authors:  Giovanni Sitia; Masanori Isogawa; Kazuhiro Kakimi; Stefan F Wieland; Francis V Chisari; Luca G Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

10.  Kinetics of viremia and acute liver injury in relation to outcome of neonatal woodchuck hepatitis virus infection.

Authors:  Yun Wang; Stephan Menne; Betty H Baldwin; Bud C Tennant; John L Gerin; Paul J Cote
Journal:  J Med Virol       Date:  2004-03       Impact factor: 2.327

View more
  24 in total

1.  Measurement of Antiviral Effect and Innate Immune Response During Treatment of Primary Woodchuck Hepatocytes.

Authors:  Marta G Murreddu; Manasa Suresh; Severin O Gudima; Stephan Menne
Journal:  Methods Mol Biol       Date:  2017

Review 2.  Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.

Authors:  Aleksei Suslov; Stefan Wieland; Stephan Menne
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

3.  Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.

Authors:  Shi Zou; Yanqin Du; Shunmei Huang; Shuilin Sun; Dongliang Yang; Jun Wu; Mingfa Chen; Xiaoli Yang; Sumeng Li; Yingshan Chen; Meihong Han; Jia Li; Qing Yu; Elisabeth Littwitz-Salomon; Hongming Huang; Mirko Trilling; Shi Liu; Rongjuan Pei; Jia Liu; Baoju Wang; Xin Zheng; Mengji Lu; Ulf Dittmer
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

4.  Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.

Authors:  Xiuji Cui; Daniel N Clark; Kuancheng Liu; Xiao-Dong Xu; Ju-Tao Guo; Jianming Hu
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

5.  Therapeutic advances in the management of chronic hepatitis B infection.

Authors:  Johanne Brooks; William Gelson; Simon M Rushbrook
Journal:  Ther Adv Chronic Dis       Date:  2013-07       Impact factor: 5.091

6.  Antiviral activity of bone morphogenetic proteins and activins.

Authors:  Lucy A Eddowes; Kinda Al-Hourani; Narayan Ramamurthy; Jamie Frankish; Hannah T Baddock; Cynthia Sandor; John D Ryan; Dahlene N Fusco; João Arezes; Eleni Giannoulatou; Sara Boninsegna; Stephane Chevaliez; Benjamin M J Owens; Chia Chi Sun; Paolo Fabris; Maria Teresa Giordani; Diego Martines; Slobodan Vukicevic; John Crowe; Herbert Y Lin; Jan Rehwinkel; Peter J McHugh; Marco Binder; Jodie L Babitt; Raymond T Chung; Matthew W Lawless; Andrew E Armitage; Caleb Webber; Paul Klenerman; Hal Drakesmith
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

Review 7.  Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection.

Authors:  Zhimin Guo; Thomas King
Journal:  Int J Mol Sci       Date:  2015-08-18       Impact factor: 5.923

8.  Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Lore Gruenbaum; Hans Bitter; Erik Rasmussen; Palanikumar Ravindran; David C Swinney; Fabian Birzele; Roland Schmucki; Stefan H Lorenz; Erhard Kopetzki; Jade Carter; Miriam Triyatni; Linta M Thampi; Junming Yang; Dalal AlDeghaither; Marta G Murreddu; Marta G Murredu; Paul Cote; Stephan Menne
Journal:  PLoS Pathog       Date:  2015-09-09       Impact factor: 6.823

9.  AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Daniela Paulsen; Olaf Weber; Helga Ruebsamen-Schaeff; Bud C Tennant; Stephan Menne
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

10.  Immunosuppressive drugs modulate the replication of hepatitis B virus (HBV) in a hydrodynamic injection mouse model.

Authors:  Junzhong Wang; Baoju Wang; Shunmei Huang; Zhitao Song; Jun Wu; Ejuan Zhang; Zhenni Zhu; Bin Zhu; Ying Yin; Yong Lin; Yang Xu; Xin Zheng; Mengji Lu; Dongliang Yang
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.